Logo for Pyxis Oncology Inc

Pyxis Oncology Inc Investor Relations Material

Latest events

Logo for Pyxis Oncology Inc

Status Update

Pyxis Oncology Inc
Logo for Pyxis Oncology Inc

Status Update

20 Nov, 2024
Logo for Pyxis Oncology Inc

Q3 2024

18 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Pyxis Oncology Inc

Access all reports
Pyxis Oncology Inc. is a clinical-stage biopharmaceutical company focused on developing therapies to treat cancer. It is focused on helping patients with cancer through a differentiated portfolio of biologics, specifically targeting tumor cells and overcoming immune suppression. Pyxis Oncology's strategy encompasses the use of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies, aiming to improve outcomes for patients with difficult-to-treat cancers. The company is headquartered in Boston, MA, and its shares are listed on the Nasdaq.